IWM
ABBV icon

IHT Wealth Management’s AbbVie ABBV Stock Holding History

IHT Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Buy
73,546
+13,542
+23% +$3M 0.37% 61
2025
Q4 		$13.7M Sell
60,004
-752
-1% -$171K 0.33% 64
2025
Q3 		$14.1M Buy
60,756
+719
+1% +$146K 0.36% 63
2025
Q2 		$11.1M Sell
60,037
-1,971
-3% -$366K 0.31% 75
2025
Q1 		$13M Sell
62,008
-778
-1% -$151K 0.41% 53
2024
Q4 		$11.2M Sell
62,786
-9,922
-14% -$1.82M 0.36% 59
2024
Q3 		$14.4M Buy
72,708
+15,284
+27% +$2.85M 0.41% 45
2024
Q2 		$9.85M Sell
57,424
-765
-1% -$127K 0.37% 53
2024
Q1 		$10.6M Buy
58,189
+1,282
+2% +$221K 0.42% 42
2023
Q4 		$8.82M Buy
56,907
+4,315
+8% +$629K 0.39% 45
2023
Q3 		$7.84M Buy
52,592
+2,129
+4% +$313K 0.4% 46
2023
Q2 		$6.8M Buy
50,463
+227
+0.5% +$33.3K 0.35% 55
2023
Q1 		$8.01M Buy
50,236
+248
+0.5% +$37.9K 0.46% 41
2022
Q4 		$8.08M Sell
49,988
-451
-0.9% -$69.2K 0.51% 38
2022
Q3 		$6.77M Buy
50,439
+7,293
+17% +$1.05M 0.51% 33
2022
Q2 		$6.61M Sell
43,146
-523
-1% -$79.9K 0.58% 30
2022
Q1 		$7.08M Buy
43,669
+1,190
+3% +$173K 0.54% 31
2021
Q4 		$5.75M Buy
42,479
+511
+1% +$60.4K 0.42% 41
2021
Q3 		$4.53M Sell
41,968
-290,998
-87% -$33.3M 0.37% 57
2021
Q2 		$37.5M Sell
332,966
-2,687
-0.8% -$303K 2.38% 3
2021
Q1 		$36.3M Buy
335,653
+37,063
+12% +$3.96M 2.61% 3
2020
Q4 		$32M Sell
298,590
-26,426
-8% -$2.54M 2.66% 3
2020
Q3 		$28.5M Buy
325,016
+279,034
+607% +$26.3M 2.86% 4
2020
Q2 		$4.51M Sell
45,982
-267,341
-85% -$23.5M 0.62% 27
2020
Q1 		$23.9M Buy
313,323
+57,066
+22% +$4.86M 3.44% 1
2019
Q4 		$22.7M Sell
256,257
-1,898
-0.7% -$158K 2.69% 3
2019
Q3 		$19.6M Buy
258,155
+46,849
+22% +$3.21M 2.66% 2
2019
Q2 		$15.4M Buy
211,306
+26,613
+14% +$2.09M 2.23% 4
2019
Q1 		$14.9M Buy
184,693
+48,867
+36% +$4M 2.48% 2
2018
Q4 		$12.5M Buy
135,826
+109,949
+425% +$9.67M 2.41% 2
2018
Q3 		$2.45M Buy
25,877
+2,191
+9% +$208K 0.53% 36
2018
Q2 		$2.19M Buy
23,686
+3,068
+15% +$300K 0.56% 37
2018
Q1 		$1.89M Sell
20,618
-259
-1% -$28.5K 0.51% 37
2017
Q4 		$2.08M Buy
20,877
+5,547
+36% +$523K 0.55% 30
2017
Q3 		$1.39M Sell
15,330
-1,018
-6% -$77.5K 0.59% 36
2017
Q2 		$1.17K Sell
16,348
-343
-2% -$23.1K 0.57% 33
2017
Q1 		$1.08M Buy
16,691
+2,891
+21% +$182K 0.72% 21
2016
Q4 		$861K Buy
+13,800
New +$842K 0.65% 29

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IHT Wealth Management's ABBV Position: Q1 2026 in Review

IHT Wealth Management increased its AbbVie (ABBV) stake by 23% in Q1 2026, buying an estimated $3M and bringing the position to 73,546 shares worth $16M. The position accounts for 0.37% of the portfolio, ranked #61.

IHT Wealth Management first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $37.5M in Q2 2021. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • IHT Wealth Management held 73,546 shares of AbbVie worth $16M as of Q1 2026.
  • IHT Wealth Management bought 13,542 AbbVie shares in Q1 2026, an estimated $3M.
  • AbbVie made up 0.37% of IHT Wealth Management's portfolio in Q1 2026, its #61 holding.
  • IHT Wealth Management first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
  • IHT Wealth Management's AbbVie position peaked at $37.5M in Q2 2021.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.